← All organizations
Highest phase reached
Phase 4
First clinical trial
Apr 27, 2017Last known activity
Jan 20, 2026
Timeline
No events for the selected filters.
Drugs by trial phase (50 distinct, 37 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (13 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (3 own, 0 via acquisition)
Other trials (25 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT07289971Lead sponsorPhase 3Jan 20, 2026
- NCT07289971Sponsor investigatorPhase 3Jan 20, 2026
- NCT07301775Sponsor investigatorPhase 4Jan 1, 2026
- NCT07301775Lead sponsorPhase 4Jan 1, 2026
- NCT07208799Sponsor investigatorPhase 2Dec 1, 2025
- NCT06950632Sponsor investigatorN/AOct 20, 2025
- NCT06950632Lead sponsorN/AOct 20, 2025
- NCT07288619Lead sponsorN/AOct 15, 2025
- NCT07288619CollaboratorN/AOct 15, 2025
- NCT07288619Sponsor investigatorN/AOct 15, 2025
- NCT07199088Sponsor investigatorN/AOct 11, 2025
- NCT07199088Lead sponsorN/AOct 11, 2025
- NCT07183514Lead sponsorN/ASep 20, 2025
- NCT07183514Sponsor investigatorN/ASep 20, 2025
- NCT07212452Lead sponsorPhase 2/Phase 3Aug 1, 2025
Details
- Last known activity
- Jan 20, 2026